Psychiatry prior authorization at Premera Blue Cross
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Premera Blue Cross psychiatry PA at a glance
Premera Blue Cross reviews psychiatry PA submissions against its medical policy library, with rules drawn primarily from APA Clinical Practice Guidelines + SAMHSA TIP series for SUD. Premera Blue Cross-specific context: BCBS licensee for Washington and Alaska (~2.4M members). Express Scripts PBM. WA OIC oversight. WA has strong mental health parity enforcement and surprise-billing protections that pre-date federal NSA.
Documentation packet — what to send
- DSM-5-TR diagnosis with ICD-10
- Prior medications: drug, dose, duration, response, reason for change
- Severity / safety markers (PHQ-9, GAD-7, suicide risk assessment)
- Concurrent therapy / case-management notes
- For MOUD: SUD diagnosis confirmation and treatment plan
Common denial patterns to pre-empt
Patterns observed in psychiatry across payers, and where Premera Blue Cross's book of business overlaps:
- Step therapy through SSRIs/SNRIs before atypical antipsychotics
- Stimulant quantity limits
- MAT (medication-assisted treatment): step therapy or counselling-bundled requirement
- Off-label use for refractory depression / anxiety
- Mental Health Parity (MHPAEA) violations — disparate NQTLs
- WA-specific mental health parity violations
- Step therapy via Express Scripts
Appeal angles when Premera Blue Cross denies
- APA practice guideline citation
- Mental Health Parity and Addiction Equity Act (MHPAEA) parity argument when medical/surgical equivalent not similarly restricted
- Documented treatment-resistance (failed trials with adequate dose + duration)
- Suicide risk or functional impairment severity
Peer-to-peer prep
- Quote the APA guideline recommendation strength
- For parity arguments: cite MHPAEA + the specific NQTL disparity
- Have the PHQ-9 / GAD-7 score history on hand
- For MOUD denials: cite SAMHSA evidence base + the patient's harm-reduction story
Drug-specific PA criteria at Premera Blue Cross
Deep dives on each drug's PA criteria at Premera Blue Cross:
Frequently asked questions
What documentation does Premera Blue Cross need for psychiatry prior authorizations?
Premera Blue Cross's PA packet for psychiatry typically includes: DSM-5-TR diagnosis with ICD-10; Prior medications: drug, dose, duration, response, reason for change; Severity / safety markers (PHQ-9, GAD-7, suicide risk assessment); Concurrent therapy / case-management notes. APA Clinical Practice Guidelines + SAMHSA TIP series for SUD citations strengthen the submission.
What's the turnaround at Premera Blue Cross?
Premera Blue Cross standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which psychiatry drugs does Premera Blue Cross most often PA-restrict?
Top targets in psychiatry: methylphenidate, lisdexamfetamine, buprenorphine, naltrexone. Each follows the per-drug step therapy + documentation requirements published in Premera Blue Cross's medical policy library.
How do I prep a peer-to-peer with Premera Blue Cross in psychiatry?
Quote the APA guideline recommendation strength For parity arguments: cite MHPAEA + the specific NQTL disparity Have the policy URL and the patient's chart open before the call.
Generate a Psychiatry PA packet
Open ApprovalHelp — generate a psychiatry PA packet tailored to Premera Blue Cross's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com